- Lilly (Hartford, CT)
- …+ Experience in Neurodegenerative Disease and/or Oncology reimbursement + Demonstrated ability to conduct field -based customer support and ... who need them, improve the understanding and management of disease , and give back to our communities through philanthropy...the Customer Experience Hub at Lilly USA, LLC, the Field Reimbursement Manager (FRM) is a … more
- University of Southern California (Los Angeles, CA)
- …neurogenomics, and deep learning to study the aging brain in health and disease , particularly in neurodegenerative conditions like Alzheimer's disease (AD). ... throughout the university, leads the way in defining and advancing the field of gerontology: https://gero.usc.edu The Irimia Laboratory leverages neuroimaging,… more
- Harvard University (Cambridge, MA)
- …in new and established techniques for profiling of EVs from human biofluids in neurodegenerative disease and other disease states. + Provide training and ... + Bachelor's degree in a biological science or related field is required. Two or more years of research...your professional growth and development through mentorship and tuition reimbursement to support continued learning, and more. We also… more
- New York Genome Center (New York, NY)
- …specifically on disease -based research in the following areas: neuropsychiatric disease (autism, schizophrenia, bipolar); neurodegenerative disease (ALS, ... of new technology in the production services, and individual disease -area grants. There is the option of having an...Position Requirements + Advanced degree in Genetics or related field of study or 10+ years experience in the… more
- New York Genome Center (New York, NY)
- …specifically on disease -based research in the following areas: neuropsychiatric disease (autism, schizophrenia, bipolar); neurodegenerative disease (ALS, ... sets, and by experimental approaches. Our lab includes experts across the field of systems genetics, from statistical genetics and genomics to molecular genomics.… more
- New York Genome Center (New York, NY)
- …specifically on disease -based research in the following areas: neuropsychiatric disease (autism, schizophrenia, bipolar); neurodegenerative disease (ALS, ... is the prime recipient institution. + Review purchase orders, Concur reimbursement requests, invoices for compliance with grant/funding terms, and NYGC's internal… more
- New York Genome Center (New York, NY)
- …specifically on disease -based research in the following areas: neuropsychiatric disease (autism, schizophrenia, bipolar); neurodegenerative disease (ALS, ... CRISPR perturbations and single-cell sequencing. Our lab includes experts across the field of systems genetics, from statistical genetics and genomics to molecular… more
- New York Genome Center (New York, NY)
- …specifically on disease -based research in the following areas: neuropsychiatric disease (autism, schizophrenia, bipolar); neurodegenerative disease (ALS, ... a private, not-for-profit entity, the NYGC operates in a notable public field and reporting requirements over time will emulate public company standards.… more
- New York Genome Center (New York, NY)
- …specifically on disease -based research in the following areas: neuropsychiatric disease (autism, schizophrenia, bipolar); neurodegenerative disease (ALS, ... & Qualifications + Bachelors' degree in Molecular Biology, Biotechnology, Biochemistry, or related field required; + 4 years of experience in a molecular biology lab… more
- New York Genome Center (New York, NY)
- …specifically on disease -based research in the following areas: neuropsychiatric disease (autism, schizophrenia, bipolar); neurodegenerative disease (ALS, ... Bachelor's degree in Computer Science, Bioinformatics, Computational Biology, or a related field , or equivalent experience required; an advanced degree is a plus. *… more
- Arvinas (New Haven, CT)
- …the discovery, development, and commercialization of therapies that degrade disease -causing proteins. Arvinas uses its proprietary PROTAC (R) Discovery Engine ... protein disposal system to selectively and efficiently degrade and remove disease -causing proteins. The company is progressing multiple investigational drugs through… more